BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3663938)

  • 1. Phorbol esters sensitize platelets to activation by physiological agonists.
    Siess W; Lapetina EG
    Blood; 1987 Nov; 70(5):1373-81. PubMed ID: 3663938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ mobilization primes protein kinase C in human platelets. Ca2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C.
    Siess W; Lapetina EG
    Biochem J; 1988 Oct; 255(1):309-18. PubMed ID: 3143357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation. A novel synergism.
    Siess W; Lapetina EG
    Biochem J; 1989 Oct; 263(2):377-85. PubMed ID: 2574568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways.
    Hannun YA; Greenberg CS; Bell RM
    J Biol Chem; 1987 Oct; 262(28):13620-6. PubMed ID: 3115982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of rap1B by protein kinase A is not involved in platelet inhibition by cyclic AMP.
    Siess W; Grünberg B
    Cell Signal; 1993 Mar; 5(2):209-14. PubMed ID: 7684600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+.
    Powling MJ; Hardisty RM
    Thromb Res; 1986 Oct; 44(2):185-95. PubMed ID: 3787566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potentiation of phorbol ester-induced aggregation of human platelets by the prostaglandin endoperoxide analogue, U46619.
    Edwards MC; Williamson EM; Evans FJ
    J Pharm Pharmacol; 1987 May; 39(5):370-7. PubMed ID: 2886585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextran-70 inhibits equine platelet aggregation induced by PAF but not by other agonists.
    Heath MF; Evans RJ; Hayes LJ
    Equine Vet J; 1998 Sep; 30(5):408-11. PubMed ID: 9758098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
    Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
    Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phorbol diesters and teleocidin on normal human platelets.
    Cech P; Rosove MH; Harwig SS; Lehrer RI
    Thromb Res; 1986 May; 42(3):383-96. PubMed ID: 2940726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca2+ flux in human platelets.
    MacIntyre DE; McNicol A; Drummond AH
    FEBS Lett; 1985 Jan; 180(2):160-4. PubMed ID: 2981715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inhibitor of collagen-induced platelet aggregation from the saliva of Triatoma pallidipennis.
    Noeske-Jungblut C; Krätzschmar J; Haendler B; Alagon A; Possani L; Verhallen P; Donner P; Schleuning WD
    J Biol Chem; 1994 Feb; 269(7):5050-3. PubMed ID: 8106481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation.
    Nunn B
    Thromb Res; 1983 Sep; 31(5):657-63. PubMed ID: 6648898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
    Joseph S; Krishnamurthi S; Kakkar VV
    Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
    Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
    Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase.
    Brass LF; Woolkalis MJ; Manning DR
    J Biol Chem; 1988 Apr; 263(11):5348-55. PubMed ID: 2833506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.